The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:805-812, May 2006
doi: 10.1176/appi.ajp.163.5.805
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lam, R. W.
* Articles by Tam, E. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lam, R. W.
* Articles by Tam, E. M.
Related Collections
* Seasonal Affective Disorder
* Other Treatment
* Antidepressants

The Can-SAD Study: A Randomized Controlled Trial of the Effectiveness of Light Therapy and Fluoxetine in Patients With Winter Seasonal Affective Disorder

Raymond W. Lam, M.D., F.R.C.P.C., Anthony J. Levitt, M.B.B.S., F.R.C.P.C., Robert D. Levitan, M.D., F.R.C.P.C., Murray W. Enns, M.D., F.R.C.P.C., Rachel Morehouse, M.D., F.R.C.P.C., Erin E. Michalak, Ph.D., and Edwin M. Tam, M.D.C.M., F.R.C.P.C.

OBJECTIVE: Light therapy and antidepressants have shown comparable efficacy in separate studies of seasonal affective disorder treatment, but few studies have directly compared the two treatments. This study compared the effectiveness of light therapy and an antidepressant within a single trial. METHOD: This double-blind, randomized, controlled trial was conducted in four Canadian centers over three winter seasons. Patients met DSM–IV criteria for major depressive disorder with a seasonal (winter) pattern and had scores ≥23 on the 24-item Hamilton Depression Rating Scale. After a baseline observation week, eligible patients were randomly assigned to 8 weeks of double-blind treatment with either 1) 10,000-lux light treatment and a placebo capsule, or 2) 100-lux light treatment (placebo light) and fluoxetine, 20 mg/day. Light treatment was applied for 30 minutes/day in the morning with a fluorescent white-light box; placebo light boxes used neutral density filters. RESULTS: A total of 96 patients were randomly assigned to a treatment condition. Intent-to-treat analysis showed overall improvement with time, with no differences between treatments. There were also no differences between the light and fluoxetine treatment groups in clinical response rates (67% for each group) or remission rates (50% and 54%, respectively). Post hoc testing found that light-treated patients had greater improvement at 1 week but not at other time points. Fluoxetine was associated with greater treatment-emergent adverse events (agitation, sleep disturbance, palpitations), but both treatments were generally well-tolerated with no differences in overall number of adverse effects. CONCLUSIONS: Light treatment showed earlier response onset and lower rate of some adverse events relative to fluoxetine, but there were no other significant differences in outcome between light therapy and antidepressant medication. Although limited by lack of a double-placebo condition, this study supports the effectiveness and tolerability of both treatments for seasonal affective disorder and suggests that other clinical factors, including patient preference, should guide selection of first-line treatment.




This article has been cited by other articles:


Home page
IOVSHome page
S. Thompson, R. F. Mullins, A. R. Philp, E. M. Stone, and N. Mrosovsky
Divergent Phenotypes of Vision and Accessory Visual Function in Mice with Visual Cycle Dysfunction (Rpe65rd12) or Retinal Degeneration (rd/rd)
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2737 - 2742.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol, June 1, 2008; 22(4): 343 - 396.
[Abstract] [PDF]


Home page
Evid. Based Ment. HealthHome page
B. N Gaynes
Light therapy and fluoxetine similarly effective for improving seasonal affective disorder
Evid. Based Ment. Health, February 1, 2007; 10(1): 26 - 26.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Terman and J. S. Terman
Controlled Trial of Naturalistic Dawn Simulation and Negative Air Ionization for Seasonal Affective Disorder
Am J Psychiatry, December 1, 2006; 163(12): 2126 - 2133.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Light Therapy or Antidepressants for Seasonal Affective Disorder?
Journal Watch Psychiatry, June 7, 2006; 2006(607): 7 - 7.
[Full Text]


Home page
BMJHome page
Light therapy and fluoxetine both work in seasonal affective disorder
BMJ, June 3, 2006; 332(7553): .
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, May 27, 2006; 332(7552): 1282 - 1282.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Light Therapy or Antidepressants for Seasonal Affective Disorder?
Journal Watch (General), May 9, 2006; 2006(509): 8 - 8.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org